ASTH Astrana Health, Inc.

bullish track record → $32.55 +1.10 (+3.5%)
Get emailed when ASTH changes direction
Mkt Cap $2B P/E 68.4 fwd 10.5 52wk $18.08 - $34.80 Earnings 2026-05-07 48d ago
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net +1.2)

Factor Model

net +1.2 2.2 / 10
Est. Revisions
+0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+1.0
Narrative Gap
+0.0

Q4 EPS crushes consensus by 5x, stock pops 30%

Watch: Monitor forward guidance and margin trajectory on the next earnings call. Whether this Q4 beat was one-off or the start of sustained profitability will determine if the stock can hold these gains or if the rally was relief-driven.

Astrana Health delivered a blowout Q4 earnings report, posting $0.54 EPS against consensus expectations of $0.11—a 5x beat. Revenue came in at $950.5 million, modestly above the $930.5 million consensus. The stock responded with a 29.5% single-day jump to $26.32 on Monday, signaling sharp investor relief on profitability.

This isn't just a beat; it's a credibility reset. The magnitude of the EPS surprise suggests either analyst estimates were severely off base or Astrana executed materially better than expected in Q4. A 5x EPS beat paired with an immediate 30% rally points to investor confidence in the underlying business model turning profitable.

Evidence

7d ago Baird main ASTH: Outperform → Outperform
48d ago Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday benzinga
51d ago Astrana Health Posts Upbeat Q4 Earnings, Joins AeroVironment, Kratos Defense & Security Solutions And Other Big Stocks Moving Higher On Monday benzinga
Fundamentals & Data ▾
Astrana Health, Inc. Healthcare · Medical Care Facilities
Mkt Cap
$2B
P/E
68.4 fwd 10.5
Beta
0.77
52w Range
$18.08 - $34.80
Short Interest
2.9M 8.11%
Days to Cover
5.3 -2%
Technicals downtrend
from 52w Hi
0.0%
1w return
+12.0%
Insiders
mixed 0B / 0S
Analysts
mixed
EPS Estimate
$0.65 1up / 0dn
Est. Dispersion
0% 1 analysts
Analyst Target
$36 $26 - $50
Options P/C
0.04
Fund Convergence
strong D.E. Shaw, Renaissance, Citadel, Two Sigma
Financials
Revenue
$951M +43% YoY
FCF
$-6M
Gross Margin
10%
Op Margin
2%
Momentum: decelerating
Top Holders
D.E. Shaw $18M
Renaissance $2M
Citadel $1M
Two Sigma
Recent Filings & Data
insider trade 43
net selling
12 insiders · 43 transactions (30d)
Recent transactions
SIM KENNETH T · award
SIM BRANDON · award
LAM THOMAS S · award
KUMAR DINESH M · award
SIM BRANDON · exercise · $495,802
SCHMIDT DAVID · exercise · $115,800
LAM THOMAS S · exercise · $524,546
SIM KENNETH T · exercise · $524,546
MAZDYASNI MATTHEW · exercise · $364,000
KITAYAMA MITCHELL W · exercise · $218,400
MARSH LINDA · exercise · $364,000
KITAYAMA MITCHELL W · exercise · $145,600
SCHMIDT DAVID · exercise · $364,000
CHIANG JOHN · exercise · $364,000
CHIANG JOHN · award
MARSH LINDA · award
MAZDYASNI MATTHEW · award
KITAYAMA MITCHELL W · award
DAI WEILI · award
SCHMIDT DAVID · award
SOBOTKA GLENN · award
SIM BRANDON · award
KUMAR DINESH M · award
BASHO CHANDAN · award
KITAYAMA MITCHELL W · exercise · $62,760
CHIANG JOHN · exercise · $27,891
SIM KENNETH T · exercise · $523,058
SIM KENNETH T · award
SIM BRANDON · award
KUMAR DINESH M · award
BASHO CHANDAN · award
LAM THOMAS S · award
MARSH LINDA · exercise · $168,850
KITAYAMA MITCHELL W · exercise · $168,850
CHIANG JOHN · exercise · $168,850
LAM THOMAS S · exercise · $523,058
SCHMIDT DAVID · exercise · $231,610
CHIANG JOHN · award
MARSH LINDA · award
MAZDYASNI MATTHEW · award
KITAYAMA MITCHELL W · award
DAI WEILI · award
SCHMIDT DAVID · award
3 signals · latest 7d ago

Get alerted when ASTH changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →